Target intelligence / Profile preview

Bile acid-CoA:amino acid N-acyltransferase (BAAT)

Target
BAAT
Molecular classification
Enzyme, Acyltransferase
01

Overview

Bile acid-CoA:amino acid N-acyltransferase (BAAT) is a cytosolic, liver-predominant enzyme that catalyzes the conjugation of bile acids (mainly cholic acid and chenodeoxycholic acid) to the amino acids glycine and taurine, a critical step in bile acid metabolism and homeostasis. This amidation increases the detergent properties of bile acids in the gastrointestinal tract, facilitating the absorption of dietary fats and fat-soluble vitamins. BAAT is encoded by the BAAT gene (chromosome 9q22.3-9q31.1) and plays a role in the regulation of bile acid pool characteristics and enterohepatic recycling. Recent findings indicate a broader role in the synthesis of N-acyl taurines, a class of bioactive lipids implicated in glucose and lipid metabolism. Deficiency or genetic defects in BAAT can lead to disorders of bile acid metabolism, with clinical manifestations related to impaired bile flow, fat malabsorption, and hepatic dysfunction

Other names
BACATBATGlycine N-choloyltransferaseCholoyl-CoA:glycine N-choloyltransferaseAmino acid N-choloyltransferaseBile acid-CoA thioesteraseCholyl-CoA glycine-taurine N-acyltransferaseCholyl-CoA:taurine N-acyltransferase
02

Mechanism of action

Substrate for bile acid conjugation (glycine, taurine); Modulation of bile acid pool composition (potentially relevant for drugs altering bile acid metabolism)

03

Biological functions

Bile acid metabolismBile acid conjugationLipid absorptionFat-soluble vitamin absorptionRegulation of free fatty acid levelsBiosynthesis of N-acyl taurines
04

Disease associations

Other (Disorders in bile acid metabolism, risk of cholestasis, inborn errors of metabolism)
05

Safety considerations

Accumulation of unconjugated bile acids (can cause hepatic toxicity, cholestasis)Impaired lipid absorption (can lead to fat-soluble vitamin deficiency)
06

Interacting drugs

None specifically documented; bile acid analogs and derivatives may potentially interact but are not well-characterized for modulation of BAAT activity
07

Biomarkers

Conjugated bile acid levels in serum or urine (reflect BAAT activity)Serum or urinary N-acyl taurines (experimental/research setting)

Beyond the preview

Go deeper on Bile acid-CoA:amino acid N-acyltransferase (BAAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile acid-CoA:amino acid N-acyltransferase (BAAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call